Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

Dr. David Dodwell is a Senior Clinical Research Fellow. He came to Oxford after more than 20 years as a consultant working in the NHS based in Leeds and he has a major clinical and research interest in breast cancer.

He now works full time in NDPH within the ‘Benefits and Risks of Cancer Treatment Programme’ and the Early Breast Cancer Trialists’ Collaborative Group.

From the perspective of a clinician with much experience in clinical trials, he will discuss the progress that has been made in the management of breast cancer over the last few decades. He will also assess the strengths and limitations of randomized evidence in improving the management of patients.

Forthcoming events

The ecology and evolution of microbial communities

Monday, 13 January 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Health and economic impacts of Lassa vaccination campaigns in West Africa

Monday, 20 January 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar room

Host-parasite interactions

Monday, 27 January 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Marburg vaccine trial

Monday, 03 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Tuberculosis vaccine R&D and human challenge models

Monday, 10 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Shingles vaccine and dementia, and other links between infectious diseases and brain health

Monday, 24 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms